The level of inhibin A in the blood serum of women suffering from chronic trichomoniasis as a predictor of infertility

Cover Page

Cite item

Full Text

Abstract

Aim. To determine the relationship between the level of inhibin A and biochemical factors of inflammation with the development of infertility in women suffering from chronic trichomoniasis.

Methods. The object of the study was the blood serum of 167 women suffering from chronic trichomoniasis. The level of inhibin A was determined by enzyme immunoassay. As a control, the blood serum of 22 practically healthy fertile women was used who had no history of trichomoniasis. The lymphocyte phenotype was determined using luminescent microscopy with monoclonal antibodies staining. The level of immunoglobulins in serum was determined by the standard Mancini method of radial immunodiffusion. The synthesis of cytokines was determined by the method of studying the spontaneous synthesis of interleukins-1β, -8, -10 and interferon γ. The level of cytokines and lactoferrin was evaluated by enzyme immunoassay. The concentrations of α2-macroglobulin and C-reactive protein were determined by the nephelometric method. The fibrinogen concentration was determined by the coagulometric method.

Results. In the group of patients with chronic trichomoniasis, a significant variability in the serum concentration of inhibin A from 4.3 to 29.4 ng/L was found. In a group of patients who had a reduced content of inhibin A, in 63.2% of cases, the development of secondary infertility was subsequently diagnosed; in the group of patients who had a normal level of inhibin A, secondary infertility developed only in 12.9% of cases.

Conclusion. It was found that among all acute phase proteins, only levels of C-reactive protein and lactoferrin have prognostic value and statistically significantly differ in groups of women with subsequently developed infertility and uncomplicated infertility trichomoniasis.

About the authors

N I Gudinskaya

Astrakhan State Medical University

Email: oboyko08@mail.ru
SPIN-code: 5906-5854
Russian Federation, Astrakhan, Russia

O V Boyko

Astrakhan State Medical University

Author for correspondence.
Email: oboyko08@mail.ru
SPIN-code: 3043-7974
Russian Federation, Astrakhan, Russia

N A Gribova

Clinical Maternity Hospital

Email: oboyko08@mail.ru
Russian Federation, Astrakhan, Russia

R I Mukhamedzyanova

Astrakhan State Medical University

Email: oboyko08@mail.ru
Russian Federation, Astrakhan, Russia

References

  1. Ahmad I., Jagtap D.D., Selvaa Kumar C. et al. Molecular characterization of inhibin-A: Structure and expression analysis in Clariasbatrachus. Gen. Comp. Endocrinol. 2018; 261: 104–114. doi: 10.1016/j.ygcen.2018.02.007.
  2. Kristensen S.G., Mamsen L.S., Jeppesen J.V. et al. Hallmarks of human small antral follicle development: Implications for regulation of ovarian steroidogenesis and selection of the dominant follicle. Front. Endocrinol. (Lau­sanne). 2018; 8: 376. doi: 10.3389/fendo.2017.00376.
  3. Singnoi W., Wanapirak C., Sekararithi R., Tongsong T. A cohort study of the association between maternal serum Inhibin-A and adverse pregnancy outcomes: a po­pulation-based study. BMC Pregnancy Childbirth. 2019; 19 (1): 124. doi: 10.1186/s12884-019-2266-y.
  4. Gallastegui N., Coe R.M., Torres A., Harrington T.J. Thrombocytopenia associated with high levels of inhibin. A case study. Blood Cells Mol. Dis. 2019; 76: 22–24. doi: 10.1016/j.bcmd.2019.01.001.
  5. Pangas S.A., Rademaker A.W., Fishman D.A., Woodruff T.K. Localization of the activin signal transduction components in normalhuman ovarian follicles: implications for autocrine and paracrine signaling in the ovary. J. Clin. Endocrinol. Metab. 2002; 87 (6): 2644–2657. doi: 10.1210/jcem.87.6.8519.
  6. Baerwald A., Vanden Brink H., Hunter C. et al. Age-related changes in luteal dynamics: preliminary associations with antral follicular dynamics and hormone production during the human menstrual cycle. Menopause. 2018; 25 (4): 399–407. doi: 10.1097/GME.0000000000001021.
  7. Gaccioli F., Aye I.L.M.H., Sovio U. et al. Screening for fetal growth restriction using fetal biometry combined with maternal biomarkers. Am. J. Obstet. Gynecol. 2018; 218 (2S): S725–S737. doi: 10.1016/j.ajog.2017.12.002.
  8. Bukulmez O., Arici A. Assessment of ovarian reserve. Curr. Opin. Obstetr. Gynecol. 2004; (16): 231–237. doi: 10.1097/00001703-200406000-00005.
  9. Simbirtsev A.S. Cytokines in the pathogenesis of human infectious and non-infectious diseases. Meditsinskiy akademicheskiy zhurnal. 2013; (3): 18–41. (In Russ.)
  10. Boyko O.V., Akhmineeva A.H., Boyko V.I., Gudinskaya N.I. Influence of Astrakhan gas processing plant on the air pollution by harmful chemical substances of industrial premises and the territory. Gigiena i sanitariya. 2016; 95 (2): 167–171. (In Russ.)
  11. Askari S.G., Khatbasreh M., Ehrampoush M.H. et al. The relationship between environmental exposures and hormonal abnormalities in pregnant women: An epidemiological study in Yazd, Iran. Women Birth. 2018; 31 (3): e204–e209. doi: 10.1016/j.wombi.2017.09.002.
  12. Boyko O.V., Terent'ev A.A., Nikolaev A.A., Chomaev A.M. Moleku­lyarnye mekhanizmy persistiruyushchey infektsii. (Mole­cular mechanisms of persistent infection.) Astrakhan: Izdatel'skiy dom “Astrahanskiy universitet”. 2006; 127 p. (In Russ.)

Supplementary files

Supplementary Files
Action
1. JATS XML

© 2019 Gudinskaya N.I., Boyko O.V., Gribova N.A., Mukhamedzyanova R.I.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.





Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).